EP3848027 - Bibliographic data
MODULATEURS DE RECEPTEURS DE GLUCOCORTICOIDE AZADECALINE FUSIONNEE OCTAHYDRO
| Last update | 14/06/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Européen |
| (73) Holder |
Corcept Therapeutics Incorporated 149 Commonwealth Drive
Menlo Park, CA 94025
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Hazel HUNT Edenderry House
Bracken Close
Storrington, West Sussex
Royaume-Uni
Iain WALTERS Bio City
Pennyfoot Street
Nottingham, Nottinghamshire NG1 1GF
Royaume-Uni
Benoit GOURDET Bio City
Pennyfoot Street
Nottingham, Nottinghamshire NG1 1GF
Royaume-Uni
|
| (74) Agent |
Mail recipient
OFFICE FREYLINGER SA BP 48 - 234, ROUTE D'ARLON,
8001
STRASSEN
Luxembourg
|
| (21) Request number | EP21158231.7 |
|---|---|
| (22) Request date | 21/11/2014 |
| (11) Publication number | EP3848027 |
|---|---|
| Publication date | 05/04/2023 |
| (54) Title of the invention | MODULATEURS DE RECEPTEURS DE GLUCOCORTICOIDE AZADECALINE FUSIONNEE OCTAHYDRO |
|---|---|
| (51) International classification | A61K 31/4162, A61K 31/4375, C07D 471/04, C07D 498/04 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201361908333 P |
|---|---|
| Initial application | None |
| Divisional application | EP23157691.9 /EP4219494 None |
| Expected annuity | Annuity: 12 - Amount: 285 € - Due date 01/12/2025 |
|---|---|
| Last annuity | Annuity: 11 - Payment date 29/10/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 05/04/2023 Constitution de mandataire pour un dossier - Legal date 17/04/2023 |